Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : UNDERVALUE STOCKS WITH SMALL FLOAT. -- Ignore unavailable to you. Want to Upgrade?

To: Wink who wrote (353)	2/14/1999 11:31:00 AM
From: Taki	Read Replies (1) \| Respond to of 452

NASDAQ REQUIRES $1.00 PER SHARE FOR SMALL CAP NASDAQ, AND THIS COMPANY IS A REPORTING COMPANY. OTBB does not require share price to stay on the BB the new rule. Just to be reporting company with the new rule. And EDII is a reporting company. So there will be no pink sheets for this company, but there will be Nasdaq small cap, and $1.00 per share, without I said without a reverse split, and that is a guaranty from the company. I suggest to you to call the CFO John Stump of EDII to verify all this. Number is 1-281-334-4764. Give him a call and you will be glad you did Sir.

To: Wink who wrote (353)	2/15/1999 3:22:00 PM
From: Wink	Respond to of 452

POLXF - Polydex Pharmaceuticals Outstanding 3M Float 2M Insiders hold almost 1M shares PE = 8 Price $3.25 52 Week Range $2 - $6.75 year ends Jan 31 Trades at: 5.7x cash flow (37.6 for industry) 0.8 price to sales (8.6 for industry) 1.4 price to book (8.5 for industry) Earnings have been on the rise the last 2 years and the upcoming year end numbers should beat last years'. They have lagged the industry in revenue growth but is starting to remedy that with the most recent year. Net margins are much higher than the industry at 10.6%. I will be buying on Tuesday. ;>)